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1CHAPTER 1
Introduction
The neural basis of decision making has long been elusive and often considered to be 
too broad of a problem to be tractable. Several authors (Fuster, 2001;Goldman-Rakic, 
1996;Krawczyk, 2002;Miller, 1999) have presented the prefrontal cortex (PFC) as the 
key brain region associated with high-level, “executive” processes needed for voluntary 
goal-directed behavior. Evidence for this includes an extensive neurological history of  
aberrations in the decision making process of patients with  sustained lesions in the 
frontal  regions of the brain. Ever since Harlow (Harlow, 1999) described the famous 
case of Phineas Gage, it  has been known that lesions in orbital  PFC often produce 
dramatic changes in personality (Damasio et al., 1994). Despite the extensive literature 
describing  this  type  of  abnormality,  little  is  known  about  the  molecular  and  cellular 
mechanisms within  the PFC that  regulate  neuronal  excitability and could  eventually 
underlie  the  process  of  decision  making  and  other  brain  functions  driven  by  the 
prefrontal cortex.
Multiple studies have correlated changes of activity in the PFC with diverse behavioral 
manifestations, in example, in vivo studies have found multiplicative effects on firing rate 
during changes in attention or behavioral  state (McAdams and Reid, 2005). Several 
mechanisms have been proposed, including variations in background noise, inhibitory 
synchrony and neuronal inhibition in order to explain how alterations in neuronal firing  
rates  can  lead  to  changes  in  behavior.  Higgs  (Higgs  et  al.,  2006)  described  a 
mechanism of modulation of input gain, capable of modifying input signals of pyramidal  
2neurons.  In  these  cells,  large  afterhyperpolarizations  promote  suprathreshold 
coincidence detection and gain increase, thus allowing them to discriminate between 
input  stimuli  into  pyramidal  neurons.  This  study  highlights  the  relevance  of  these 
afterpotentials  in  the  regulation  of  neuronal  excitability  of  pyramidal  neurons  in  the 
prefrontal cortex which ultimately might contribute to the understanding of higher brain 
process such as human decision making.
Afterhyperpolarizations in cortical pyramidal cells
The afterhyperpolarizations  seen  in  pyramidal  cells  have  been  dissected  into  three 
components based on their pharmacological and kinetic features and named the fast 
afterhyperpolarization (fAHP), the medium AHP (mAHP), and the slow AHP (sAHP). The 
fAHP is activated during a single action potential and lasts tens of milliseconds. Single 
channel recordings identified a large conductance Ca2+-activated K+ channel sensitive to 
tetraethylammonium (TEA), termed BK or maxi-K channel, to be the channel underlying 
the fAHP (Adams et al.,  1982;Marty,  1981;Pallotta  et  al.,  1981).  The mAHP, and its 
underlying current (ImAHP), is also rapidly activated following the action potential (<5 ms) 
but decays with a time course of several hundred milliseconds. This afterpotential is 
inhibited  by  the  bee-venom  toxin  apamin,  and  thus  is  referred  to  as  the  apamin-
sensitive  component  of  the  AHP  (Schwindt  et  al.,  1988a;Storm,  1989).  There  is 
accepted  consensus  that  small-conductance  Ca2+-dependent  K+ (KCa2.X;  SK1-3) 
channels are responsible for the appearance of this current (Bond et al., 2004;Schwindt 
et al., 1988b;Stocker et al., 1999;Villalobos et al., 2004). Finally, the third component of  
the  AHP,  the  sAHP,  is  generally  seen  after  a  train  (4-10)  of  spikes  (Faber  et  al.,  
2001;Lancaster and Nicoll, 1987;Schwindt et al., 1988b), rises to a peak over several 
3hundred milliseconds and can last up to 5 seconds following a train of action potentials. 
The identity of the channel(s) underlying the sAHP has proven elusive. Initial studies 
suggested that a member of the SKCa channels family (KCa2.1, SK1) could be a potential 
molecular  candidate for  sAHP (Bond et  al.,  1999;Kohler  et  al.,  1996;Vergara  et  al.,  
1998).  However,  more  recent  studies  have  shown  that  SKCa channels  are  solely 
responsible for the ImAHP and do not contribute to the IsAHP (Bond et al., 2004;Villalobos et 
al.,  2004). Thus the identity of the Ca2+-activated K+ channel(s) underlying the sAHP 
remains an unsolved mystery.
The sAHP
In the early 1980s, a series of studies described and characterized the properties of the 
long lasting sAHP that followed firing of neurons in the central nervous system. This 
series of studies showed that this hyperpolarizing potential was mediated by calcium-
dependent potassium currents activated following action potentials or epileptiform burst 
in  hippocampal  CA1-CA3 pyramidal  neurons and other  cell  types (Alger  and Nicoll,  
1980;Hotson and Prince, 1980;Schwartzkroin and Stafstrom, 1980). This long lasting 
sAHP  controls  spike  frequency  accommodation  in  these  cells  (Faber  and  Sah, 
2003;Vogalis  et  al.,  2003)  and regulates neuronal  gain (Higgs et  al.,  2006).  Similar 
sAHPs have also been reported in many other cell  types, suggesting that the sAHP 
functions as a ubiquitous regulator of neuronal excitability.  A general property of this 
sAHP is that it is inhibited by neuromodulators acting through the Gαq-11/Phospholipase 
Cβ or  through the Gαs/adenylate cyclase/cAMP/Protein kinase A signaling cascades 
(Krause et al.,  2002;Nicoll,  1988;Pedarzani  and Storm, 1993). Thus the sAHP is an 
4important determinant of cellular excitability in a variety of cell types in the CNS and an 
important target for a variety of neuromodulators.
Calcium activation of IsAHP
Although IsAHP is understood as a potassium current activated by calcium influx through 
voltage activated calcium channels, exactly how these potassium channels are gated by 
calcium remains unclear. One clue in this regard is that the slow rise and decay of this  
current has been reported to track intracellular bulk calcium rather than the calcium 
concentration immediately below the plasma membrane (Abel et al., 2004;Jahromi et 
al., 1999;Sah and Clements, 1999). Several hypotheses have been proposed to explain 
this observation, among them, that the channels involved in I sAHP activation would be 
located far from the point of calcium influx, therefore the time course of the macroscopic 
currents will  simply reflects the diffusion of free calcium to the K+ channels. Another 
theory suggests that the kinetic of the macroscopic currents is due to the slow kinetic of  
the  underlying  channels.  Even  though  these  hypotheses  could  explain  the  kinetics 
differences  between  calcium  influx  and  IsAHP,  evidence  discarding  them  was  soon 
obtained (Lancaster and Adams, 1986;Lancaster and Nicoll, 1987;Sah, 1995;Sah and 
Isaacson, 1995;Sah and McLachlan, 1991;Schwindt et  al.,  1992).  A third theory has 
proposed  that  calcium  influx  might  activate  a  second  messenger  system,  which 
ultimately opens the channels that underlie the IsAHP thus explaining the discrepancy 
between calcium influx and IsAHP kinetics (Abel et al.,  2004;Gerlach et al.,  2004;Sah, 
1996a;Schwindt et al., 1988a). 
5A recent breakthrough into elucidating the mechanism of IsAHP was the observation that 
genetic deletion of hippocalcin, a member of the neuronal calcium sensor (NCS) protein 
family,  resulted  in  an  inhibition  of  this  current  in  hippocampal  pyramidal  cells.  In 
addition, expression of hippocalcin in primary culture of hippocampal neurons induced 
the appearance of a robust IsAHP (Tzingounis et al., 2007). These results have led to the 
idea  that  hippocalcin  is  the  calcium  sensor  for  the  IsAHP (Tzingounis  et  al.,  2007). 
However, this idea is not without its limitations. First, while IsAHP is broadly expressed in 
many regions of the brain, hippocalcin expression seems to be much more restricted 
(Paterlini et al., 2000;Saitoh et al., 1994). Furthermore, hippocalcin deletion inhibits but 
does  not  abolish  IsAHP.  These  considerations  suggest  that  other  proteins  besides 
hippocalcin may be capable of functioning as a calcium sensor for IsAHP. 
Ion channels mediating IsAHP
In spite of very extensive efforts by many groups, little is known at the present time 
about the identity of the channels carrying IsAHP. For example, single channel analyses 
have shown remarkable heterogeneity in the properties of putative IsAHP channels in 
different  cells  (Vogalis  et  al.,  2003).  Furthermore,  genetic  and  pharmacological 
approaches have shown that while Kv7 (KCNQ) channels contribute in part to I sAHP in 
granule cells of the dentate gyrus, they do not contribute to IsAHP in pyramidal cells of the 
CA1 region (Tzingounis and Nicoll, 2008). These observations raise the possibility that 
IsAHP may not be a unitary current and may be carried by different potassium channels 
depending on the cellular background. 
6To know how IsAHP is modulated would be an important contribution to our understanding 
of how neuronal excitability is regulated in PFC because the sAHP plays an important 
role in setting the neuronal gain and is regulated by a variety of neuromodulators. Since 
recent  evidence tend to  suggest  that  IsAHP may not  be product  of  a  single calcium-
activated potassium channel, but rather multiple channels, the understanding of how 
IsAHP gets modulated becomes of greater importance. A distinctive feature of IsAHP is its 
modulation  by  several  neurotransmitters,  however,  the  intracellular  pathways  and 
second messengers involved in this process tend to vary depending on the brain region 
and cell  type tested [reviewed in (Nicoll,  1988;Sah, 1996b)]. The mechanism of I sAHP 
inhibition by monoamines (noradrenaline, dopamine, histamine, and serotonin) involves 
cAMP as a second messenger and the activation of protein kinase A (Andrade and 
Nicoll, 1987a;Benardo and Prince, 1982;Haas and Konnerth, 1983;Madison and Nicoll, 
1986b;Madison  and  Nicoll,  1982;Madison  and  Nicoll,  1986a;Pedarzani  and  Storm, 
1993;Torres et al., 1995). Protein kinase A, as well as protein kinase C do not take part  
in the modulation of IsAHP by muscarinic and mGluR agonist (Blitzer et al., 1994;Gerber 
et  al.,  1992;Pedarzani  and  Storm,  1993;Sim et  al.,  1992).  Furthermore,  cAMP/PKA 
pathway seems not to be involved in IsAHP inhibition by either serotonin or muscarinic 
receptor activation in pyramidal neurons of PFC; instead PLC/IP3-DAG seems to be the 
intracellular pathway of choice. These multiple intracellular signaling pathways, together 
with the hypothesis of multiple ion channels involved in IsAHP activation, lead to the idea 
that IsAHP activation and modulation form part of a ubiquitous mechanism for regulation of 
neuronal excitability rather than be a particular feature of a specific neuronal type.
7In the present dissertation I investigate the role of hippocalcin, and other NCS proteins,  
in the regulation of IsAHP in pyramidal neurons of the prefrontal cortex. I also show that 
PtdIns(4,5)P2 is essential for the functional expression and gating of IsAHP and that this 
phosphoinositide acts downstream from calcium in the gating of IsAHP.
8CHAPTER 2
Material & Methods
Brain slices experiments. Whole-cell recordings were obtained from pyramidal cells of 
layer V of the anterior cingulate and somatosensory cortex derived from rat and mouse 
brain slices. For these experiments we used either acute brain slices prepared from 
animals aged postnatal day 15 to 30 (P15-P30) or slices in organotypic culture derived 
from animals aged postnatal day 8-12 (P8-P12) maintained in culture from 2-3 days. To 
prepare the brain slices, the anterior pole of the brain was removed and cooled in ice 
cold cutting Ringer (composition in mM: 119 NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2, 1 
NaH2PO4, 26.2 NaHCO3, 10 HEPES and 11 glucose; bubbled to saturation with 95%O2, 
5%CO2). The isolated brain was then affixed to a block with cyanoacrylate glue, and cut 
using a vibratome (Lancer series 1000, Ted Pella, Irvine, CA) to produce 300µM thick 
coronal brain slices. Acute slices were transferred to a holding chamber where they 
were allowed to recover for at least 1 h in same cutting Ringer’s solution.
Electrophysiological recordings. Brain slices were placed one at a time in a recording 
chamber (Sakmann and Stuart, 1995) on the stage of a Nikon (Melville, NY) E600FN 
microscope. Slices were superfused with standard Ringer’s solution (in mM: 119 NaCl, 
2,5 KC, 125 KmeSO4,  l,  1.3  MgSO4,  2.5  CaCl2,  1 NaH2PO4,  26.2 NaHCO3,  and 22 
glucose,  bubbled  to  saturation  with  95%  O2-5%  CO2)  at  30°±1°C.  Neurons  were 
visualized using differential interference contrast (DIC) or fluorescence, and recordings 
were  obtained  using  3-4  MΩ  electrodes  filled  with  a  potassium-based  intracellular 
solution (in mM: 125 KMeSO4, 5 KCl, 5 NaCl, 0.02 EGTA, 11 HEPES, 1 MgCl2, 10 Na2 
9phosphocreatine,  4  MgATP,  and  0.3  NaGTP;  pH  7.3).  In  some  experiments  this 
intracellular solution was supplemented with  10-30mM of  myo-inositol  (Fisher et  al.,  
2002) and the concentration of KMeSO4 was reduced to maintain osmotic equilibrium. 
Signals were amplified using Multiclamp 700B (Molecular Devices, CA), digitized and 
stored. In voltage-clamp experiments, cells were held at -60mV and AHP currents were 
elicited  using  100-msec long steps  to  +20mV in  1µM TTX to  prevent  spontaneous 
synaptic potentials and allow calcium into the cell to trigger the AHPs (Stocker et al., 
1999). ImAHP was measured 30-50 msec after the end of the depolarizing step, a time 
empirically determined to correspond to the peak of the apamin-sensitive ImAHP. IsAHP was 
measured ∼300 msec after the end of the depolarizing step, when IsAHP is near its peak 
and  ImAHP has  decayed  by  ∼90%  (Abel  et  al.,  2004).  For  calcium  measurements, 
electrodes were filled with an intracellular recording solution containing (in mM): 130.5 
KMeSO4, 10 KCl, 7.5 NaCl, 2 MgCl2, 10 HEPES, 2 ATP, 0.2 GTP and 100µM fura-2 
pentapotassium salt (Molecular Probes/Invitrogen, Carlsbad, CA).
Plasmid  transfection. Pyramidal  neurons  were  transfected  using  either  in  utero 
electroporation (RNAi  experiments)  or  particle  mediated gene transfer  (GFP-PHPLCδ1, 
InPP5B and NCS expression experiments). In utero electroporation, experiments were 
conducted on embryonic mice at embryonic gestation day 13 to 14 (E13-14) essentially 
as described by Saito (Saito, 2006). These experiments used a pool of five shRNAs 
targeting hippocalcin to maximize the suppression of hippocalcin expression (Parsons 
et al., 2009). These shRNAs have been developed by the RNAi consortium and were 
expressed from the U6 promoter in the pLKO.1-puro vector (Sigma, Mission RNAi). YFP 
in pCAG (Addgene) at 4:1 ration was electroporated with the shRNA as a transfection 
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marker. Particle mediated gene transfer in slices maintained in organotypic culture was 
conducted  as  previously  described  (Villalobos  et  al.,  2004;Yan  et  al.,  2009).  Gold 
particles were coated with plasmids encoding for the desired protein (GFP-PHPLCδ1: a 
kind  gift  of  Dr.  Tobias  Meyer,  Stanford),  InPP5B:  in  pCMV-Sport6,  ATCC  Cat  No.  
10324723/Mammalian  Gente  Collection,  Image  ID  4457437;  hippocalcin:  in  pCMV-
Sport6, ATTCC Cat. No. 10470251/Mammalian Gene Collection, Image ID 5360894); 
neurocalcin-δ:  in  pCMV-Sport6,  ATCC  Cat.  No.  MGC-36496/Mammalian  Gene 
Collection, Image ID 5365560; VILIP-2: in pcDNA3.1, a kind gift of Dr W.A. Catterall,  
Univ.  of  Washington (Lautermilch et  al.,  2005)).  EGFP (pEGFP-N1, Clontech) or m-
cherry at  a 4:1 ratio was cotransfected as transfection marker.  In  all  these vectors,  
expression of the protein mRNA was driven by CMV promoter, which effectively drives 
gene expression in this preparation (Beique and Andrade, 2003;Vogalis et al., 2003). 
Transgenic animals. The PLCβ1 knockout mouse was a kind gift  of Drs. R.K. Wong 
(Suny  Downstate  Medical  Center,  Brooklyn,  Ny)  and  H.S.  Shin  (Korea  Institute  of 
Science and Technology, Seoul, Korea) (Kim et al., 1997).
Experimental  strategy. Experiments  examining  the  effect  of  the  shRNA  targeting 
hippocalcin  compared  pyramidal  neurons  in  the  transfected  side  of  the  brain,  as 
identified  by expression  of  YFP,  with  untransfected  pyramidal  neurons at  the  same 
cortical  depth  on  the  opposite  side  of  the  brain.  We  chose  to  use  cells  in  the 
nontransfected contralateral side because preliminary studies indicated that while YFP 
allowed for clear identification of transfected neurons, lack of detectable YFP expression 
in  vivo could not be used to unambiguously select for  untransfected neurons in the 
transfected brain hemisphere.
11
In  gene  transfer  experiments,  overexpression  of  the  desired  protein  was  generally 
assessed  using  paired  recordings  from  neighboring  transfected  and  untransfected 
pyramidal neurons located within 150 µm of each other at a comparable cortical depth. 
This approach was preferred to using mock transfection in separate slices from controls 
as it  provided for a more stringent cell  match with respect to cell  location and slice  
history. We have previously shown that transfection with EGFP has no detectable effect  
on IsAHP (Yan et  al.,  2009)  and the very low transfection efficiency of  the gene gun 
technique  assured  that  the  overwhelming  fraction  of  non-GFP expressing  cells  will 
correspond to untransfected neurons.
Drugs were prepared as concentrated stock in H20 and kept frozen. They were thawed 
immediately  before  the  experiments  and  administered  to  the  slice  dissolved  in  the 
standard Ringer solution at known concentration. Most drugs were obtained from Sigma 
or Fisher. Tetrodotoxin (TTX) was obtained from Calbiochem/EMD Biosciences. Apamin 
was obtained from Tocris. Statistical comparisons used t-test.
12
CHAPTER 3
Role of Neuronal Calcium Sensor (NCS) Proteins in the Development of Slow 
Afterhyperpolarizing Currents
Depolarizing steps are capable of opening voltage-activated calcium channels in cortical 
pyramidal cells and the consequent calcium influx activates calcium-activated 
potassium channels which in turn elicit a biphasic aftehyperpolarizing current. As 
outlined in the introduction, this calcium-activated aftercurrent is known to be composed 
of two kinetically and pharmacologically distinctly currents, an early faster apamin-
sensitive component (ImAHP), mediated by KCa2.X (SK) channels and a late, slow apamin-
insensitive component (IsAHP). IsAHP can be pharmacological isolated by using low 
concentration of the bee venom apamin (300nM, applied to the bath) which specifically 
inhibits SK channels, therefore abolishing selectively the ImAHP (Fig1A). Unless otherwise 
noted, most of the experiments involving IsAHP measurements were recorded in the 
present of apamin to avoid ImAHP contamination.
To detect optimal conditions for eliciting IsAHP,  pyramidal cells were held at -60mV in 
voltage-clamp  configuration  and  voltage  step  increments  from  -60  to  +30mV  were 
applied. This protocol induced increasing calcium influx and elicited IsAHP of escalating 
amplitudes (Fig 1B). The amplitude of the resulting IsAHP increased in a sigmoid fashion 
and reached a plateau close to +20mV (Fig 1C). Therefore we used 100ms depolarizing 
steps to +20mV as the standard way to activate IsAHP unless otherwise mentioned.
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Figure  1.  IsAHP in  pyramidal  cells  of  the 
prefrontal cortex. A. Representative trace of 
an afterhyperpolarizing current elicited using a 
depolarizing pulse from -60mV to +20mV in 
the  absence  (black  trace)  and  presence  of 
apamin  (300nM,  red  trace).  B. IsAHP elicited 
using a 100ms long step from -60mV to -40, 
-20 and +20mV recorded in the presence of 
apamin. C. Dependence of IsAHP amplitude on 
the  triggering  voltage  step  amplitude.  The 
cells were held at -60mV and IsAHP was elicited 
using  100ms long  depolarizing  steps  to  the 
voltage  indicated  in  the  X  axis.  Current 
amplitude was normalized with respect to the 
maximal current obtained for each cell. n = 15
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Role of hippocalcin on IsAHP development in pyramidal neurons of the prefrontal cortex
As mentioned above, the observation that genetically modified mice lacking the NCS 
protein hippocalcin showed reduced IsAHP amplitude lead Tzingounis (Tzingounis et al., 
2007) to hypothesize of a significant role of this protein in the development of I sAHP. To 
test this idea we aimed to reduce the levels of hippocalcin in pyramidal neurons of the 
prefrontal cortex to assess its role as the putative protein responsible for the I sAHP. In a 
first set of experiments, we used in utero electroporation to express a pool of shRNAs to 
knockdown  hippocalcin  in  layer  II/III  pyramidal  cells  of  cingulated  cortex.  Previous 
studies have shown the effectiveness of this approach to knockdown the expression of 
specific proteins (Bai et al., 2003;Parsons et al., 2009). However, because the in utero 
electroporation approach has not been used before to study electrophysiological effects 
in  the  medial  prefrontal/anterior  cingulated  cortex  we  first  sought  to  test  the 
effectiveness of the transfection system in this area. To that effect we transfected YFP 
fluorescent protein together with the potassium channel Kir2.1 into mice (E14) in order 
to obtain both a fluorescent and a biological marker of positively transfected cells. As 
expected,  we  found  sparse  labeling  of  layer  II/III  pyramidal  cells  showing  green 
fluorescence in only one hemisphere in slices obtained from transfected mice (slices 
obtained  from  mice  P10-21).  At  the  electrophysiological  level,  pyramidal  cells 
expressing YFP/Kir2.1 showed a more hyperpolarized membrane resting potential than 
neighboring  non-fluorescent  cells  recorded  from the  same  hemisphere  or  the  non-
transfected hemisphere. One potential issue when selecting the proper negative control  
for this experiment is whether the lack of detectable YFP expression in the transfected 
hemisphere  can  be  used  as  an  unambiguous  selection  criteria  for  untransfected 
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neurons.  To  examine  this  issue  we  compared  the  ability  of  BaCl2 100µM,  a  well 
established  Kir2.1  channel  blocker,  to  reduce  the  Kir2.1-induced  outward  current 
between YFP-expressing and non expressing close neighboring pyramidal cells within 
the same hemisphere. Figure 2A shows holding current from individual cells (in voltage 
clamp configuration, -60mV) before (open circles)  and after  BaCl2 application (black 
circles). Red bars indicate the average with standard error for each column.  When 
comparing non-YFP (left panel) with YFP-expressing cells (center panel) from the same 
transfected  hemisphere,  we  observed  a  significant  reduction  in  the  BaCl2-induced 
inhibition of the Kir2.1-mediated outward current. However, when comparing non-YFP 
expressing  cells  from  the  transfected  hemisphere  with  pyramidal  cell  from  the 
contralateral  non-transfected  hemisphere  (right  panel)  we  also  found  a  significant 
difference in BaCl2-induced inhibition between them despite the fact that both groups 
could have been classified as “untransfected controls”. Figure 2B depicts the average 
BaCl2-induced  inhibition  at  cells  from  ipsilateral  non-YFP,  ipsilateral  YFP  and 
contralateral cells (BaCl2-induced inhibition: non-YFP/ipsilateral: 96.58 ± 16.74 pA; YFP-
positive/ipsilateral: 161.91 ± 14.30 pA; non-YFP/contralateral: 58.041 ± 10.19 pA). This  
result  indicates  that  non-YFP  expressing  cells  from  the  transfected  ipsilateral 
hemisphere cannot  be used reliably as “non-transfected control”  cells  and therefore 
might not be the best negative control for this experiment. For this reason, we compared 
YFP-expressing cells from the transfected ipsilateral hemisphere with cells matched for  
location  from  the  contralateral  untransfected  side  as  negative  control  for  in  utero 
electroporation  transfection  experiments.  These  results  validate  the  in  utero 
16
electroporation transfection system as a suitable tool to transfect plasmids into specific 
layers within the prefrontal cortex and identified suitable control cells.
17
 Fig
ure 2. 
In 
utero electroporation  effectively  transfects  layer  II/III  pyramidal  cells  from  cingulate 
cortex. Test of YFP/Kir2.1 co-transfection as a marker for transfected and untransfected cells 
following  in  utero electroporation.  A. Cells  were  held  at  -60mV  and  100µM  barium  was 
administered to block standing Kir2.1 currents. Individual Kir2.1 currents recordings before and 
after barium administration from ipsilateral non-YFP expressing controls (left panel), ipsilateral 
YFP-expressing  cells  (center  panel)  and  non-transfected  location-matched  cells  from 
contralateral  hemisphere  (right  panel).  B. Averaging  of  barium-induced  inhibition  of  Kir2.1 
currents recorded from ipsilateral non-YFP expressing (gray bar), ipsilateral YFP-positive (green 
bar) and untransfected cells from contralateral hemisphere (open bar). These results do not 
support the idea that non-YFP pyramidal cells of the transfected side could be used as controls 
for transfected YFP-positive cells.
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As illustrated in Fig 3, knockdown of hippocalcin resulted in a significant reduction in the 
amplitude of IsAHP in  pyramidal  cells.  Figure 3A depicts  representative traces of IsAHP 
recorded  from  an  YFP-expressing  cell  from  the  ipsilateral  transfected  hemisphere 
(green trace) and a control cell matched for location from the contralateral side (black 
trace). Insert shows DIC (upper panel) and fluorescence (lower panel) images of a slice 
from a P15 mice transfected with YFP/shRNA-hippocalcin depicting both transfected 
(left)  and  untransfected  (right)  hemisphere.  Figure  3B  summarizes  IsAHP amplitudes 
recorded  from  individual  YFP-positive  cells  from  the  transfected  side  compared  to 
pyramidal  cells  matched  for  location  on  the  opposite  non-transfected  side.  The 
corresponding IsAHP amplitude values were: control 27.16 ± 4.6 pA; shRNA hippocalcin 
9.06 ± 2.5 pA. Red bars, average and standard error.
19
Figure 3. siRNA hippocalcin knockdown reduces IsAHP amplitude. A. Superimposed traces 
illustrating IsAHP recorded from shRNA/YFP transfected (green) and contralateral untransfected 
control  (black) mouse pyramidal cells.  Inset,  cingulate cortex (transfected and untransfected 
hemispheres) in a living slice imaged using DIC (upper panel) and fluorescence (lower panel). 
Calibration  bar  =  100µm.  B. Summary  plot  depicting  the  IsAHP amplitude  in  5  shRNA/YFP 
transfected and 9 position  matched untransfeceted cells  from the contralateral  hemisphere. 
*p<0.05
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To corroborate  the  knockdown  of  hippocalcin  after  in  utero YFP/shRNA-hippocalcin 
transfection  we  proceeded  to  do  an  immunohistochemical  analysis  on  slices  from 
transfected mice. Figure 4A shows the ipsilateral hemisphere of a brain slice obtained 
from a  P15  mouse  transfected  with  YFP/shRNA-hippocalcin.  YFP-positive  cells  are 
shown in green, while cells expressing hippocalcin are shown in red. A drawing of the 
transfected  hemisphere  depicting  the  cingulate  cortex  where  the  product  of  the 
transfection appears is shown in the insert. Due to the restricted level of transfection by 
in  utero electroporation,  only  a  limited  number  of  cells  will  express  the  shRNA-
hippocalcin at the cortex. To better appreciate the knocking down of hippocalcin we 
analyzed  hippocalcin  expression  on  YFP-positive  cells.  Figure  4B shows  magnified 
views of cingulate cortex from figure 4A. YFP-positive cells (white arrows) were single 
identified by fluorescence (left  panel).  By switching color  channels,  the presence of  
hippocalcin (middle panel) was evaluated on the same previously targeted cell. In this 
set of pictures, we could appreciate that there was no hippocalcin-related fluorescence 
in the YFP-positive cells, corroborating the knocking down of hippocalcin in the cells  
transfected with YFP/shRNA-hippocalcin, while consistent hipoocalcin expression could 
be observed in most of the non-YFP expressing cells. Merged images (right panel),  
further  corroborate  this  observation.  These  results,  confirm  the  knockdown  of 
hippocalcin on layer II/III pyramidal cells by transfection of a pool of shRNA-hippocalcin  
through  in  utero electroporation  and  support  idea  that  hippocalcin  is  an  important 
contributor for the development of IsAHP in pyramidal cells of the prefrontal cortex.
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 Figure 4. Knockdown of hippocalcin expression by electroporation of shRNAs directed 
against hippocalcin in the cerebral cortex. A. Low magnification confocal image illustrating 
hippocalcin  (red)  and  YFP immunoreactivity  (green)  in  the  anterior  cerebral  cortex.  Image 
depicts  a  mosaic  built  from  multiple  contiguous  images  obtained  at  single  optical  plane. 
Calibration bar: 500µm. B. Close-up images depicting three subregions within image A. Notice 
that strongly YFP immunoreactive cells (arrows) generally express little if any hippocalcin. A rare 
exception is denoted by the uppermost arrow in the third row of images to illustrate that co-
detection of YFP and hippocalcin in the green and red channels is possible. Calibration bar: 
100µm.  Antibodies:  rabbit  α-hippocalcin  (Abcam  ab24560)  and  rabbit  α-GFP  (Invitrogen, 
A11122).
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One potential  limitation  of  this  knockdown  experiment  is  that  hippocalcin  has  been 
suggested  to  act  as  a  sensor  for  neuronal  activity  (Amici  et  al.,  2009)  and  thus 
suppressing its expression could result in homeostatic changes in neuronal excitability. 
Any homeostatic change, however, can be expected to be minimized when hippocalcin 
is  acutely  expressed.  Therefore  we  transfected  hippocalcin  into  pyramidal  cells  in 
cortical slices maintained in organotypic cultures and assessed its effect on I sAHP using 
paired  recordings  from  neighboring  transfected  and  untransfected  pyramidal  cells 
(Beique et al., 2007;Yan et al., 2009). As illustrated in Fig 5, expression of hippocalcin  
(green trace) resulted in a large increased in IsAHP amplitude that was accompanied by a 
significant  slowing of  the decay kinetics of  this  aftercurrent  (inserts  Fig  5A and 5B) 
(p<0.05).  These  loss  of  function  and  overexpression  experiments  indicate  that 
hippocalcin is an important protein involved in the regulation of the amplitude of IsAHP in 
cortical pyramidal cells.
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Figure 5. Hippocalcin overexpression greatly increases IsAHP amplitude. A. Superimposed 
traces depicting IsAHP recorded in a pair of pyramidal cells overexpressing hippocalcin (green 
trace)  and  neighboring  untransfected  (black  trace)  from rat  organotypic  slices.  Inset,  same 
recordings scaled to emphasize the change in the time course of IsAHP. B. Plot summarizing the 
effects of hippocalcin expression on the amplitude and rate of decay (insert) of IsAHP for each cell 
pair tested in this experiment. The half decay graph depicts only 11 cell pairs because it was not 
possible to estimate the half decay for IsAHP in one of the control cells.
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The only partial inhibition of IsAHP by suppression of hippocalcin expression described by 
Tzigounis (Tzingounis et al., 2007) raised the possibility that other members of the NCS 
protein family could act  in conjunction with  hippocalcin as calcium sensors for IsAHP. 
Hippocalcin shares considerable sequence homology with the NCS protein neurocalcin-
δ and  VILIP-3  and  previous  studies  have  suggested  this  proteins  may  form  a 
functionally  distinct  subfamily  of  visinin-like  proteins  (Braunewell  and  Klein-Szanto, 
2009;Burgoyne, 2007). Therefore, we next proceeded to transfect neurocalcin-δ, a close 
homolog of hippocalcin (91% amino acid identity), and examined its effect on IsAHP. As 
illustrated  in  figure  6A1,  expression  of  neurocalcin-δ (green  trace),  like  hippocalcin, 
resulted  in  a  large  increase  in  IsAHP amplitude  comparing  to  untransfected  control 
neighboring cells (black trace)(Fig 6A1, insert; IsAHP amplitude, control: 56.68 ± 9.71 pA; 
neurocalcin-δ: 98.69 ± 10.052 pA). Analysis of paired recordings corroborates this result 
(Figure 6A2). Similarly as with hippocalcin, cells transfected with neurocalcin-δ showed a 
slower IsAHP kinetic (Figure 6A3) (p<0.05). In contrast, transfection of VILIP-2, a more 
distant member of the hippocalcin subfamily of NCS proteins (<70% amino acid identity) 
had no effect on either IsAHP amplitude or decay kinetics (Figures 6B1, B2 and B3; IsAHP 
amplitude, control: 52.306 ± 15.51 pA; VILIP-2: 48.48 ± 11.97 pA; p=0.85). Combined 
these results indicate that IsAHP can be regulated by at least two members of the visinin-
like subfamily of NCS proteins.
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Figure 6. Neurocalcin-δ, but not VILIP-2 increase the amplitude and prolong duration of 
IsAHP. A1. Superimposed traces of IsAHPs recorded from a cortical pyramidal cell transfected with 
neurocalcin-δ (green)  and  from  its  neighboring  untransfected  control  (black)  in  the  same 
organotypic slice. Inset, summary plot illustrating the effect of neurocalcin-δ on IsAHP amplitude in 
8 cell pairs. *p<0.05.  A2 and A3. Graphs illustrating the effects of neurocalcin-δ expression on 
the amplitude (A2) and rate of decay (A3) of IsAHP for each cell pair tested in this experiment. The 
half-decay for only 7 cell pairs is depicted in A3 because it was not possible to estimate its value 
for one of the control cells. A3, insert. Scaled traces from A1 to illustrate the slower time course 
of neurocalcin-δ enhanced IsAHP. B1. Superimposed traces of IsAHPs recorded in cortical pyramidal 
cells transfected with VILIP-2 (green) and a neighboring untransfected control cell (black). Inset, 
summary graph depicting IsAHP amplitude in control cells and in cells transfected with VILIP-2. B2 
and B3. Graphs illustrating the effects of VILIP-2 on the amplitude (B2) and rate of decay (B3) of 
IsAHP for each pair tested in this experiment. n=5 cell pairs tested. p=0.49
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NCS proteins sensitivity to calcium
Hippocalcin  and  neurocalcin-δ are  expressed  in  the  cerebral  cortex  in  a  roughly 
overlapping pattern suggesting coexpression at the cellular level (Figure 7, extracted 
from Allen Brain Atlas). Previous work has suggested that two or more NCS proteins 
exhibiting different calcium affinities may work in tandem to extend the dynamic range of 
calcium sensing (Burgoyne, 2007). Thus, we considered the possibility that hippocalcin 
and neurocalcin-δ could sense different calcium concentrations to activate IsAHP. To test 
this idea we examined the apparent calcium sensitivity of IsAHP under controlled calcium 
influx conditions after transfection with either hippocalcin or neurocalcin-δ. As illustrated 
in  figure  8,  hippocalcin  and  neurocalcin-δ,  but  not  VILIP-2  (figures  8A,  8B and  8C 
respectively),  produce  rightward  shifts  in  the  apparent  calcium  sensitivity  of  IsAHP. 
Despite the apparently increase of sensitivity to calcium between untransfected cells 
and  cells  transfected  with  hippocalcin  or  neurocalcin-δ,  there  was  no  significantly 
difference  in  the  calcium-sensitivity  curves  between  hippocalcin  and  neurocalcin-δ 
(Figure  8D).  These  results  are  inconsistent  with  the  idea  that  hippocalcin  and 
neurocalcin-δ have  different  calcium  affinities  in  order  to  transduce  different 
concentration of calcium, thus raising the possibility of differential expression of these 
NCS proteins will depend on the cell type.
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Figure  7.  Hippocalcin  and  neurocalcin-δ mRNA distribution  in  the  medial  prefrontal 
cortex. Images are from the Allen Mouse Brain Atlas (Allen Institute for Brain Science, Lein et 
al.,  2007).  Hippocalcin:  Detail  from  Hpca_376  (position:  9400).  Neurocalcin-δ:  Detail  from 
Ncald_386 (position: 9650). Calibration bar: 1mm.
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Figure  8.  Effect  of  hippocalcin,  neurocalcin-d  and  VILIP-2  on  the  apparent  calcium 
sensitivity of IsAHP. Graphs depicting normalized hippocalcin (A), neurocalcin-δ (B) and VILIP-2 
(C) -enhanced  IsAHP amplitudes  plotted  against  step  voltage  recorded  on  voltage-clamp 
configuration.  D. Plot  depicting  IsAHP against  step  voltage  curves  from  hippocalcin  and 
neurocalcin-δ-enhanced  IsAHP.  The  apparent  calcium  sensitivity  curves  were  almost 
superimposable. Hippocalcin, n=15 cell pairs; neurocalcin-δ,  n=6 cell  pairs; VILIP-2, n=4 cell 
pairs.
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Neuromodulation of NCS-enhanced IsAHP
Little is known at the present time about the molecular identity of the channels carrying  
IsAHP.  This  makes  it  difficult  to  unambiguously  determine  whether  hippocalcin  and 
neurocalcin-δ facilitate  the  same  channels  mediating  the  native  current.  Previous 
studies have shown that one of the defining characteristics of IsAHP is its inhibition by 
neuromodulators acting through GPCRs coupling to heterometric G proteins of the Gαs 
or Gαq/11 types (Andrade and Nicoll, 1987b;Nicoll, 1988). Therefore, we next examined 
whether the NCS-enhanced IsAHP  retains this sensitivity to neuromodulators acting via 
Gαq/11. We focused on this signaling cascade because, under our recording conditions, 
this modulation was more robust and reliable than that induced by receptors signaling 
through Gαs.
Previous  studies  have  shown  that  carbachol  inhibits  IsAHP in  pyramidal  cells  of  the 
cerebral cortex by acting on muscarinic M1/M3 receptors (Gulledge et al., 2009). At a 
biochemical level these receptors activate Gαq/11 and PLCβ leading to the breakdown of 
PtdIns(4,5)P2 (Kim et al.,  1997; Yan et al., 2009). We first tested whether carbachol 
indeed inhibited IsAHP through activation of Gαq/11 and PLCβ cascade. As illustrated in 
figure 9A-B, the ability of carbachol to inhibit IsAHP was blocked by the expression of the 
carboxy tail of PLCβ1 fused to GFP (PLCβ-ct), a dominant negative construct previously 
shown to block Gαq/11 signaling in central and peripheral neurons (Kammermeier and 
Ikeda, 1999;Yan et al., 2009). In addition, the carbachol-dependent inhibition of IsAHP was 
also greatly reduced in animals where PLCβ1 (Fig 9C), the predominant PLCβ isoform 
expressed  in  the  cerebral  cortex,  has  been  genetically  deleted  (Kim  et  al., 
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1997;Watanabe et  al.,  1998).  These results  indicated that  carbachol  inhibits  I sAHP in 
cortex through Gαq/11 and, at least in part, through PLCβ1. To examine the sensitivity of 
NCS-enhanced IsAHP to inhibition by Gαq/11 signaling we transfected pyramidal cells with 
hippocalcin or neurocalcin-δ and again examined the effects of carbachol over IsAHP. As 
illustrated in figure 10, administration of carbachol 30µM inhibited the IsAHP in a manner 
that was not statistically different from untransfected controls, thus suggesting that the 
NCS-enhanced IsAHP retain its ability to be inhibited by neuromodulators acting via Gαq/11 
and PLCβ. These set of experiments confirm the nature of NCS-enhanced IsAHP, thus 
highlighting the role of NCS in the development of IsAHP in pyramidal neurons of the 
prefrontal cortex. 
The previous results have shown that visinin-like NCS proteins accomplish a relevant 
role  in  the  development  of  IsAHP and  that  the  NCS-enhanced  IsAHP present  similar 
modulatory properties as the native current. However, these results do not provide a 
hypothesis concerning the mechanisms by which neurotransmitters inhibit this current. 
One possible explanation comes from the ability of several neuromodulators, including 
carbachol,  to  activate  Gαq/11/PLCβ1  pathways  as  previously  demonstrated.  This 
activation leads to breakdown of PtdIns(4,5)P2 in the membrane into diacyglicerol (DIG) 
and IP3, therefore it is plausible that the reduction of PtdIns(4,5)P2 levels at the plasma 
membrane  as  a  consequence  of  G  protein-couple  receptor  activation  would  be  a 
conserved  mechanism  for  IsAHP inhibition.  This  idea  proposes  a  requirement  of 
membrane PtdIns(4,5)P2 in the plasma membrane for IsAHP development. The following 
experiments aim to further investigate this hypothesis.
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Figure 9. Carbachol inhibits IsAHP through Gαq/11/PLCβ1 pathway. A. Superimposed traces 
depicting the effect of carbachol (30µM) on IsAHP recorded from pyramidal cells transfected with 
the Gαq/11 dominant negative PLCβ1-ct or from a neighboring control cell. Control = black trace; 
carbachol = red trace. B. Summary plot illustrating the effect of carbachol in control and PLCβ1-
ct transfected pyramidal cells. *p<0.001.  C. Summary plot depicting the effect of carbachol on 
IsAHP amplitude  recorded  from  pyramidal  cells  in  slices  derived  from  wild  type  and  PLCβ1 
knockout mice. *p<0.001.
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 Figure 10.  Carbachol  inhibits  native and NCS-enhanced IsAHP.  A. Superimposed  traces 
recorded from pyramidal cells transfected with hippocalcin or from untransfected neighboring 
control  cells.  Control  =  black  trace;  carbachol  =  red trace.  B. Summary graph  plotting  the 
carbachol-induced inhibition of  IsAHP in 7 control  cells  (open circles),  7 cells transfected with 
hippocalcin (black circles) and 5 cells transfected with neurocalcin-δ (gray circles). Note that 
even  in  slices  derived  from  young  animals  carbachol  was  able  to  induce  a  slow 
afterdepolarization (Yan et al., 2009), which resulted in a fractional inhibition of IsAHP bigger than 
1.
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CHAPTER 4
Involvement of PtdIns(4,5)P2 in the triggering of IsAHP
IsAHP rundowns upon prolonged whole cell recordings
Besides being activated by calcium influx, one of the most prominent features of I sAHP 
recorded in whole cell configuration is that it runs down over prolonged periods of time. 
Under  our  recording  conditions  IsAHP decreases  by  nearly  80%  within  one  hour  of 
recording without any obvious change in its time course (Figure 11A1). One may argue 
that cell integrity may be compromised during prolonged whole cell recording and that  
this could be a factor altering ion channels behavior, therefore affecting the activation of 
IsAHP.  To  test  this,  in  voltage-clamp  configuration,  we  measured  the  holding  current 
together with IsAHP to monitor cell integrity. Our results indicate that IsAHP rundown was not 
linked to a detriment of cell integrity since the holding current remained stable through 
all the recording period even though IsAHP runs down dramatically (Figure 11A2).
Since IsAHP has been described as a calcium-activated current, it is plausible to conceive 
that this rundown effect could simply reflex a decrease in calcium influx secondary to  
the rundown of calcium currents. We first assessed this possibility by examining the 
rundown of ImAHP, a second calcium-activated potassium current carried by KCa2.X (SK) 
channels that is also expressed in pyramidal cells (Villalobos et al., 2004). As illustrated 
in  figure 11B, ImAHP exhibits  little  rundown over one hour  of  recording,  a  time frame 
during  which  IsAHP undergoes  near  complete  rundown.  IsAHP and  ImAHP exhibit  partly 
overlapping time courses and therefore, to reduce contamination in the measurement of 
ImAHP for  these  experiments,  we  focused  on  pyramidal  cells  expressing  small  IsAHPs 
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(insert Fig 11B). This suggested limited rundown of calcium currents and calcium influx 
under our recording conditions. Finally,  to independently assess changes in calcium 
influx,  in  collaboration  with  Dr.  Robert  C.  Foehring,  we  conducted  calcium imaging 
experiments while simultaneously recording IsAHP (Abel  et  al.,  2004).  As illustrated in 
figure 10C, somatic and dendritic calcium transients remain stable over nearly an hour 
of  whole  recording  while  IsAHP again  exhibited  very  substantial  rundown.  These 
experiments show a clear dissociation between the rundown of IsAHP and changes in 
calcium transients and thus do not support the idea that the rundown of IsAHP is simply 
secondary to the rundown of calcium currents.
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 Fig
ure 11. 
IsAH P 
runs down upon prolonged whole-cell recording. A. IsAHP progressively runs down during 
whole-cell  configuration  when  recorded  on  a  period  longer  than  15-20  minutes.  A1. 
Representative tracings showing IsAHP reduction over time.  A2. Under our conditions, IsAHP runs 
down to about 20% of its initial amplitude after 60 minutes of whole-cell recording. IsAHP rundown 
does not correspond to changes in the holding potential of the cells as shown in the adjusted 
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holding  current  average  plot.  B. Rundown  of  the  IsAHP is  not  associated  with  changes  in 
intracellular  calcium  influx.  Time  course  plot  of  ImAHP amplitude  recorded  on  whole-cell 
configuration. Inset, representative traces depicting lack of rundown on ImAHP after 30 minutes of 
whole-cell  recording.  C.  Simultaneous IsAHP amplitude and intracellular  calcium transients (at 
apical dendrite or at the soma) showed no correlation between IsAHP rundown and intracellular 
calcium levels.  Top, representative traces of  calcium transients recorded after 0,  10 and 30 
minutes after breaking into the cell. Calcium transients are expressed as percentage of dF/F.
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Facilitating PtdIns(4,5)P2 biosynthesis protects IsAHP from rundown
This rundown effect seen on IsAHP is not unknown among ionic channel’s behavior. The 
activity of a number of them, including several potassium channels, undergoes rundown 
upon patch excision or protracted whole cell recording as a result of the progressive 
loss of  membrane PtdInd(4,5)P2 (Logothetis  et  al.,  2007;Zhang et  al.,  2003).  These 
observations  raised  the  possibility  that  the  rundown  of  IsAHP observed  in  pyramidal 
neurons of the prefrontal cortex could similarly involve loss of membrane PtdIns(4,5)P 2. 
To test  this  idea,  we took advantage of  the previous demonstration that  membrane 
PtdIns(4,5)P2 levels  can  be  effectively  manipulated  in  intact  cells  by  regulating  its 
synthesis and degradation (Li et al., 2005;Suh et al., 2006;Suh and Hille, 2002;Zhang et  
al., 2003). 
In a first set of experiments we facilitated PtdIns(4,5)P2 biosynthesis by increasing the 
availability of  inositol,  which  is  the  obligatory starting  substrate  for  the  synthesis  of 
PtdIns(4,5)P2.  In  order  to  better  appreciate  the  role  of  levels  of  inositol  on  the 
development  of  IsAHP,  we  minimized  the  de  novo inositol  biosynthesis  by  reducing 
extracellular glucose while maintaining intracellular ATP levels by including MgATP and 
phosphocreatine  in  the  intracellular  recording  solution.  This  maneuver  slightly 
augmented the rate of IsAHP rundown. To determine the effect of inositol we added myo-
inositol, a precursor of PtdIns(4,5)P2, to the intracellular recording solution (10-30mM) 
and  allowed  it  to  diffuse  into  the  pyramidal  cells.  As  illustrated  in  Fig  12A,  this  
manipulation resulted in a significant protection of IsAHP from rundown as compared with 
either cells recorded without myo-inositol or cells perfused with low-glucose extracellular 
solution.  Overall  in  this  experiment  IsAHP was found to  decay to  48±6% of  its  initial 
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amplitude within  20  minutes  of  continuous recording in  the absence of  inositol,  but 
remained at 87±5% of its initial amplitude in presence of myo-inositol. This protective 
effect of inositol persisted through the end of the experiment (60 minutes, p<0.05). A 
similar, albeit less robust, protection of IsAHP was obtained following addition of myo-
inositol to the extracellular media, a manipulation that relies on the ability of neurons to  
efficiently take up inositol (Fisher et al., 2002). 
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Figure 12. IsAHP rundown can be slowed down by addition of the inositol precursor myo-
inositol to the recording pipette. A. Time course plot depicting IsAHP amplitude rundown over 
time with regular Ringer (solid line), low-glucose extracellular solution (gray circles) and myo-
inositol added to the recording pipette in low-glucose extracellular solution (open circle). Low-
glucose extracellular solution was used to increase IsAHP rundown and thus highlight the role of 
myo-inositol.  B. To further corroborate the direct effect of myo-inositol on the reduction of IsAHP 
rundown rate we proceeded to measure calcium levels simultaneously with IsAHP amplitude in 
presence and absence of myo-inositol. B1. Picture showing a single cell filled with the calcium-
sensitive dye fura-2 in whole-cell configuration for simultaneous recording of IsAHP and calcium 
levels. Bar scale = 22µm. B2. Measurement of intracellular calcium levels plotted as normalized 
dF/F ratio showing no significant change in calcium concentrations upon addition of myo-inositol 
(black square) to the recording pipette as compared with control cell recorded without inositol 
(white squares).  Inset,  representative traces of  calcium transients recorded at  0, 10 and 30 
minutes after breaking into the cell, without and with myo-inositol in the recording pipette.
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While  these  results  supported  the  idea  that  the  rundown  of  IsAHP involved  inositol 
metabolism,  it  remained  possible  that  inositol  could  protect  IsAHP indirectly,  i.e.  by 
increasing intracellular calcium influx. Therefore we again imaged intracellular calcium 
transients as a function of time in presence and absence of myo-inositol added to the 
intracellular solution (Fig 12B1). As illustrated in figure 12B2, we could not detect any 
significant differences in calcium influx in response to addition of myo-inositol  to the 
intracellular solution. These results argued against an indirect effect on calcium entry 
and pointed to a direct effect of inositol on the stability or maintenance of IsAHP.
Taking into consideration the results described above, it is plausible to conceive the idea 
that IsAHP might be carried through a potassium channel doubly activated by calcium and 
PtdIns(4,5)P2 at the plasma membrane. One way to explain the above results would be 
that when the concentration or availability of this phospholipid gets reduced, the activity 
of these channels would be also diminished and so would IsAHP amplitude. On the other 
hand, based on the same premises, if PtdIns(4,5)P2 concentration gets increased at the 
plasma membrane, one could expect that IsAHP amplitude might be augment as well.  To 
test  this  idea,  we  perform  a  series  of  experiments  were  we  overexpressed  the 
PtdIns(4,5)P2 synthetic enzyme phosphatidylinositol 4-phosphate kinase (PIP5K) which 
is thought to be responsible for the synthesis of  most cellular PtdIns(4,5)P2 (Van & 
Divecha, 2009). In mammals, PIP5K activity is mediated by three alternatively spliced 
isoforms (Iα, Iβ and Iγ), with the gamma isoform showing the strongest expression in 
neurons (Giudici et al., 2004; Akiba et al., 2002). Therefore, for these experiments we 
used biolistic transfection (particle mediated gene transfer or “gene gun”) to transfer into  
cortical  pyramidal  cells  two  EGFP-tagged  alternative  spiced  isoforms  of  PIP5Kγ 
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(PIP5Kγ90 or PIPK5γ93; Giudici et al., 2006). These experiments were conducted in 
cortical slices in organotypic culture and we used paired recordings to examine I sAHP in 
transfected and neighboring untransfected cells  to  control  for  cell  location and slice 
history. Biolistic transfection of either of these enzymes into pyramidal cells resulted in a 
strong expression of the fused protein, as visualized by the EGFP fluorescence, which 
localized  predominantly  to  the  plasma  membrane  especially  in  dendritic  processes 
(Figure 13A). Surprisingly, expression of these enzymes had no detectable effect on 
IsAHP amplitude  at  early  times  following  whole  cell  access  (Figure  13B);  however,  it 
greatly  protected  IsAHP from  rundown  (Figure  13C1 and  13C2).  Overall  in  these 
experiments IsAHP was found to decay to 46±6% (n=8) of its initial amplitude in control 
untransfected cells within 30 minutes of recording but only to 82±6% (n=7) of its initial 
amplitude in PIP5K transfected neurons (p<0.05) and this protective effect persisted 
until the end of the experiment (p<0.05). Combined, these experiments indicated that 
increasing PtdIns(4,5)P2 biosynthesis did not increase IsAHP amplitude but protected it 
from rundown, thus rejecting the hypothesis of a direct involvement of PtdIns(4,5)P 2 in 
IsAHP activation  and  therefore  suggesting  the  idea  that  PtdIns(4,5)P2 could  be  an 
essential component for IsAHP triggering.
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Figure  13.  Facilitating  PtdIns(4,5)P2 biosynthesis  reduces  IsAHP rundown.  A. Picture 
showing expression of  PIPK5γ90-EGFP fusion protein plus m-cherry into  pyramidal  cells  of 
prefrontal cortex. PIPK5γ90 can be seen expressed in plasma membrane and dendritic process 
while m-cherry distributes homogeneously through the entire cell, mostly in the soma. B. Graph 
depicting average IsAHP amplitude recorded from cells transfected with PIPK5 and untransfected 
neighboring control. Top panel, representative traces showing IsAHP obtained from control (black) 
and PIPK5γ90 expressing pyramidal cells.  C1. Representative tracings depicting reduction of 
IsAHP rundown on cell overexpressing PIPK5. Traces were obtained from pair recordings at 5 and 
30 minutes after break into the cell.  C2. Time course plot of normalized IsAHP amplitudes from 
PIPK5-expressing cells (gray circles) and control untransfected neurons (open circles). Arrows 
indicate the time at which traces from C1 were obtained.
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Inhibiting PtdIns(4,5)P2 biosynthesis accelerates the rundown of IsAHP
If the functional expression of IsAHP depends on membrane PtdIns(4,5)P2, then inhibiting 
the synthesis of this phosphoinositide, reducing its concentration or availability at the 
plasma membrane should accelerate the rundown of IsAHP. To test this idea we first used 
the lipid kinase inhibitor wortmannin, a well  established phosphatidylinositol 4-kinase 
(PIK4) inhibitor, to inhibit PtdIns(4,5)P2 synthesis (Meyers and Cantley, 1997;Nakanishi 
et  al.,  1995).  As  illustrated  in  figure  14A,  bath  application  of  wortmannin  (10µM) 
significantly accelerated the rundown of IsAHP (middle panel) as compared with control 
cells (top panel) and resulted in the near complete disappearance of IsAHP in the course 
of the experiment. Under control conditions, IsAHP rundown to 56±6% of its initial value 
after 60 minutes but to 11±1% of its initial value in presence of wortmannin (p<0.05, Fig 
14B). Within the phosphoinositide synthetic pathway wortmannin not only inhibits the 
synthesis of PtdIns(4,5)P2 by inhibiting PIK4 but it has been reported to also inhibits 
phosphoinositide-3 kinase (PI3K). Therefore, to control  for this activity we tested the 
effect of the selective PI3K inhibitor LY 294002 on the rundown of I sAHP. As illustrated in 
figure  14A  (lower  panel)  and  14C,  administration  of  LY  294002  (10µM)  had  no 
significant  effect  on the rundown of  IsAHP when compared with  control  cells  and the 
amplitude of IsAHP in control and LY 294002 treated sliced did not differ significantly after 
60 minutes of recording (Control: 52.64 ± 3.23 %, LY 294002: 43.22 ± 6.035 %, p=0.76; 
Figures 14C and 14D). In order to rule out any secondary effect of wortmannin over 
calcium transients that could affect IsAHP,  we again simultaneously recorded IsAHP and 
imaged calcium transients in response to depolarizing voltages steps in the presence 
and  absence  of  wortmannin.  In  these  experiments,  wortmannin  accelerated  the 
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rundown of IsAHP but had little  effect on the amplitude of  the calcium transients (not 
shown) supporting the idea that PtdIns(4,5)P2 could play a role in the development of 
IsAHP.
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Figure  14.  Myo-inositol  effect  over  IsAHP rate  of  rundown  can  be  blocked  by  PI4K 
inhibition. A. Representative traces depicting increased IsAHP rate of rundown upon selective 
inhibition  of  PI4K.  Top  panel,  control  cell  showing  reduced  rundown  after  60  minutes  of 
continuous whole-cell recording (all measurements done with myo-inositol 30mM added to the 
recording pipette); medium panel, wortmannin applications increases IsAHP rundown to the extent 
of almost completely abolish its amplitude; bottom panel, PI3K selective inhibitor LY 294002 
does not affect IsAHP rate of rundown. B. time course plot of normalized IsAHP amplitude with and 
without wortmannin (10µM) added to the bath. Control, n=6; wortmannin, n=5. C. Time course 
plot of normalized IsAHP with and without LY 294002 (10µM). D. Plot of normalized IsAHPs recorded 
in control conditions (white bars), with wortmannin (black bar) and with LY 294002 (gray bar) 
measured after 50 minutes of continuous whole-cell recording.
A
C D
Wortmannin 10 Mµ
control
+ Wort 10 Mµ
B
50 pA
1 sec
control 60 min Merge
+ 
LY
 1
0
Mµ
+ 
W
or
t 1
0
Mµ
Ctrl Wort LY
0.0
0.2
0.4
0.6
0.8
1.0
*
LY 294002 10 Mµ
control
+ LY 10 Mµ
0 10 20 30 40 50 60 70
0.0
0.2
0.4
0.6
0.8
1.0
N
or
m
al
ize
d
I sA
H
P
am
pl
itu
de
Time, min
0 10 20 30 40 50 60 70
0.0
0.2
0.4
0.6
0.8
1.0
N
or
m
al
ize
d
I sA
HP
am
pl
itu
de
Time, min
48
While these experiments support the idea that the functional expression of IsAHP depends 
on PtdIns(4,5)P2, they are limited due to concerns about selectivity of wortmannin. As 
an alternative we sought for non-pharmacological ways to reduced either the levels or  
availability  of  membrane  PtdIns(4,5)P2.  Previous  experiments  have  successfully 
reduced membrane PtdIns(4,5)P2 levels by expressing 5-phosphatases (Li et al., 2005). 
Therefore,  we  used  particle-mediated  gene  transfer  to  express  the  mouse  5-
phosphatase II  (Inpp5b) in pyramidal  cells.  This phosphatase was chosen because,  
among 5’ phosphatases, this particularly isoform is well expressed in the brain (Janne et 
al., 1998), including the cerebral cortex (Allen Brain Atlas). To test the effect of Inpp5b 
on  IsAHP we  again  conducted  paired  recordings  from  transfected  and  neighboring 
untransfected pyramidal cells in organotypic slices. All experiments were conducted 24-
48 hrs after transfection. As shown in figured 15A, expression of Inpp5b resulted in a 
significant reduction of IsAHP amplitude (p<0.05). In contrast, ImAHP was not affected by 
expression of Inpp5b in pyramidal cells (insert).
Previous  studies  have  also  successfully  reduced  the  availability  of  membrane 
PtdIns(4,5)P2 using  sequestering  strategies,  which  effectively  make  this 
phosphoinositide  unavailable  to  interact  with  the  channel  of  interest  (Li  et  al., 
2005;Nakanishi et al.,  1995). Therefore we also examined the effect of sequestering 
PtdIns(4,5)P2 using the PH domain of phospholipase C-δ1 fused to GFP (GFP-PHPLCδ1)
(Stauffer et al., 1998). Previous studies have shown the effectiveness of this construct 
for binding and sequestering membrane PtdIns(4,5)P2 (Li et al., 2005;Nakanishi et al., 
1995). As depicted in figure 15B, expression of GFP-PHPLCδ1 in pyramidal cells again 
resulted in a significant reduction of the amplitude of IsAHP without any mayor alteration 
49
on ImAHP amplitude. Combined these results indicate that the functional expression of 
IsAHP depends on the availability of membrane PtdIns(4,5)P2.
50
A
B
20pA
1 sec
Control GFP-PHPLC 1δ
0
20
40
60
80
100
I sA
HP
am
pl
itu
de
,p
A
*
Control GFP-PHPLC 1δ
0
25
50
75
I
am
pl
itu
de
,p
A
40pA
1 sec
Control InPP5B
0
25
50
75
100
125
150
175
I sA
HP
am
pl
itu
de
,p
A
Control InPP5B
0
50
100
150
I
am
pli
tu
de
,p
A
*
 
51
Figure 15.  Presence of  PtdIns(4,5)P2 in the plasma membrane is a key factor  for  the 
development of IsAHP in pyramidal neurons of the prefrontal cortex. A. Overexpression of 
the phosphatidylinositol  bis-phosphate 5B (InPP5B) vector  tagged with m-cherry fluorescent 
protein into organotypic brain slices reduced IsAHP amplitude in positive-transfected fluorescent 
cells. Top panel, representative traces of InPP5B transfected and non-transfected control cell. 
Bottom panel,  averaged  IsAHP amplitudes for  InPP5B and non-transfected controls.  *p<0.05. 
Insert,  averaged  ImAHP amplitude  obtained  from  InPP5B  and  non-transfected  control 
demonstrating IsAHP-dependence on PtdIns(4,5)P2 at the plasma membrane. B. Transfection of 
the green fluorescent protein-tagged plekstrin homology domain of PLCδ1 (GFP-PHPLCδ1) into 
organotypic brain slices significantly reduced IsAHP amplitude as compared with non transfected 
cells. top panel, representative traces depicting double whole-cell recordings of a GFP-PHPLCδ1 
transfected  cell  and  a  nearby  non-transfected  control  cell.  Bottom  panel,  quantification  of 
averaged IsAHP amplitude on GFP-PHPLCδ1 transfected and non-transfected control cells. *p<0.05. 
Inset, averaged ImAHP amplitude from GFP-PHPLCδ1 and neighboring non-transfected control cells.
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Increasing membrane PtdIns(4,5)P2 facilitates the ability of calcium to activate IsAHP
Increasing  PtdIns(4,5)P2 did  not  augmented  IsAHP amplitude,  thus  ruling  out  the 
hypothesis of a direct role of PtdIns(4,5)P2 in activating the channels underlying IsAHP; 
therefore, we sought for an alternative hypothesis to explain these results. One possible 
interpretation is that PtdIns(4,5)P2 plays a permissive role for the expression of IsAHP in a 
manner  analogous  to  Kir  or  Kv7  potassium  currents.  It  has  been  previously 
demonstrated that these channels require of PtdIns(4,5)P2 in the plasma membrane for 
their  activation  (Li  et  al.,  2005;Zhang  et  al.,  2003).  Furthermore,  Kv7 channels  are 
known to be inhibited when PtdIns(4,5)P2 levels are reduced (Suh et al., 2006). Thus, in 
analogy with these channels’ properties for activation, altogether these evidences allow 
us to propose PtdIns(4,5)P2 as an essential component for IsAHP activation, although in 
this case, IsAHP would be additionally gated by calcium. Alternatively, previous studies 
have shown that potassium channels vary widely in their affinity for PtdIns(4,5)P2 and 
that at  least  some classes of potassium channels are not  fully saturated by resting  
levels  of   PtdIns(4,5)P2 (Delmas  and  Brown,  2005;Du  et  al.,  2004;Li  et  al.,  2005). 
Furthermore, there is also growing evidence that the local availability of PtdIns(4,5)P2 is 
highly  regulated  and  that  one  factor  that  regulates  this  availability  is  calcium 
(Hilgemann, 2007;McLaughlin and Murray, 2005). Therefore an alternative interpretation 
for the observation that IsAHP is dependent on PtdIns(4,5)P2 is that IsAHP represents a 
transient  calcium-induced  increase  in  the  availability  of  PtdIns(4,5)P2 which  in  turn 
activates PtdIns(4,5)P2-dependent potassium channels.  To distinguish between these 
two  possibilities  we  examined  the  calcium  sensitivity  of  IsAHP under  calcium  influx-
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controlled conditions and after increasing membrane PtdIns(4,5)P2 by overexpression of 
PIP5K.
To  examine  the  calcium  sensitivity  of  IsAHP we  used  depolarizing  steps  of  varying 
durations to elicit graded increases in calcium entry. As previously observed by others 
(Gerlach et al., 2004;Kim et al., 1997), increasing calcium influx is linked to increases in 
IsAHP.  Another  way  to  elicit  increasing  IsAHP is  by  augmenting  the  amplitude  of  the 
depolarizing  step  while  holding  its  duration  constant  (see figure  1C).  Expression  of 
either PIPKγ90 or PIPKγ93 resulted in a large increase in the  apparently sensitivity to 
calcium when using depolarizing steps shorter than 10 ms (Figure 16A), which elicited 
little or no IsAHP under control conditions but a robust, graded IsAHP  in cells transfected 
with either PIPK5 isoform. A similar results could be observed when depolarizing steps 
ranged from 10-100 ms, where cells transfected with PIPK5 reached a maximum I sAHP 
amplitude at steps as short as 20 ms, while untransfected controls did it at steps over 
80 ms (Figure 16B). Continued increases in the duration of the depolarizing pulses did 
not further elicited larger IsAHPs; as seen in figure 16C, depolarizing steps longer than 
100 ms did not increased IsAHP amplitudes in either PIPK5 or untransfected cells. These 
results are inconsistent with the idea that PtdIns(4,5)P2 plays a permissive role for the 
functional expression of IsAHP and instead point to a role of PtdIns(4,5)P2 in the gating of 
IsAHP, downstream from calcium influx.
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Figure 16. PIPK5 overexpression increases IsAHP calcium sensibility. A. Short voltage steps 
of  durations  between  1  to  10  milliseconds  elicited  small  IsAHP amplitudes  in  control  non-
transfected pyramidal  cells  (left  panel).  When similar  voltage steps were applied to PIPK5-
expressing cells,  IsAHP amplitudes were considerable  greater  (right  panel).  A1.  Plot  depicting 
average of currents (mean of 50 points, ms) elicited in control and PIPK5-expressing pyramidal 
cells. IsAHPs were elicited by depolarizing steps from -60 to +20mV of 0, 1 and 9 milliseconds of 
duration.  A2.  Averaged IsAHP amplitude of non-transfected controls (black circles) and PIP5K-
expressing  cells  (open  circles)  elicited  at  various  depolarizing  step  lengths.  B.  Increasing 
depolarizing step duration augmented IsAHP amplitude in control untransfected cell (black circles); 
on  the  other  hand,  on  PIPK5-expressing  cells  (open  circles),  IsAHP amplitudes  were  not 
significantly increased reaching its maximum amplitude at depolarizing steps as short  as 20 
milliseconds. C. Continuing increasing depolarizing step durations did not further increased IsAHP 
amplitude in neither non-transfected controls (black circles) nor PIP5K-expressing cells (open 
circles). Depolarizing steps from 100 to 600 milliseconds did not elicited greater IsAHP amplitudes.
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CHAPTER 5
Conclusions
Despite the importance and efforts involved in clarifying the identity of the ion channels 
carrying IsAHP and the mechanisms by which this current is activated by calcium, 
relatively little is still known about both of these questions. Several studies have helped 
to describe the intracellular signaling of IsAHP currents in various systems, however, the 
channels underlying this current and the mechanisms of activation leading to its 
appearance are still a very intricate puzzle.  As an example of how intricate the study of 
this current has been, not even one of its most established features, its close 
relationship to calcium influx, is yet understood. Thus, exactly how calcium influx 
activates the potassium channels underlying IsAHP remains an open question. The 
simplest explanation for this inquiry would involve calcium influxes directly activating 
IsAHP, however, a number of researchers have questioned the idea of calcium transients 
evoked during action potentials having a direct role in the activation of this current. The 
differences between calcium kinetics and IsAHP activation (Abel et al., 2004) led to the 
idea that a series of accessory proteins could mediate IsAHP activation, an the later 
observations made by Tzingounis (Tzingounis et al., 2007) that deletion of hippocalcin 
resulted in a reduction of IsAHP amplitude in hippocampal pyramidal cells further 
supported this hypothesis. However, the proposing of hippocalcin as the calcium sensor 
for IsAHP, while making much needed fresh inroads into our understanding of this current, 
raised a number of important mechanistic questions (Brown et al., 2007;Tzingounis et 
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al., 2007). The restricted expression of hippocalcin in the brain, and the partial 
suppression of IsAHP observed in the hippocalcin knockout mouse, questioned whether 
hippocalcin alone could account for the calcium sensitivity of IsAHP (Brown et al., 2007). 
In the current work we used loss of function and overexpression approaches to show 
that hippocalcin indeed regulates IsAHP in the cerebral cortex and we could also establish 
that neurocalcin-δ, a closely related visinin-like NCS protein, also mediates IsAHP. These 
results solve inconsistencies surrounding the identification of hippocalcin as the sole 
calcium sensor for IsAHP and point to a broader role of NCS protein, specifically from the 
visinin-like subfamily, in the regulation of this current.
The original suspicion that hippocalcin may not be the only calcium sensor for I sAHP was 
grounded  not  only  on  the  presence  of  a  residual  IsAHP in  the  hippocalcin  knockout 
mouse,  but  also in the observation that  this  residual  IsAHP was relatively resistant to 
inhibition by norepinephrine, acting through  β-adrenergic receptors (Tzingounis et al., 
2007). This led Brown (Brown et al., 2007) to suggest that IsAHP may be gated through 
two parallel branches exhibiting differential sensitivity to inhibition by norepinephrine. In 
the current work we show that carbachol, known to act on M1 receptors, inhibits I sAHP in 
cortical pyramidal neurons through Gαq/11/PLCβ1 pathway. Furthermore, we show that 
the native,  the hippocalcin-  and neurocalcin-δ-enhanced IsAHPs,  are all  inhibited to  a 
comparable  extent  through  this  signaling  cascade.  These  results  suggest  that  the 
Gαq/11/PLCβ1  signaling  cascade  does  not  distinguish  between  hippocalcin-  or 
neurocalcin-δ- gated IsAHP. However, these results do support the idea that hippocalcin 
and neurocalcin-δ can both transduce calcium signals and activate a common channel 
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leading to the activation of  the native IsAHP,  thus highlighting a broader  role  of  NCS 
proteins in the development of this current.
These results support the idea that of at least two distinct NCS proteins can act as 
calcium sensors  for  IsAHP.  The  idea  of  having  multiple  proteins  transducing  calcium 
signals might seem redundant if we take into consideration the possibility that two or 
more of these proteins might be co-expressed in at least some cortical neurons. On 
possible  explanation would be that  NCS proteins present  different  calcium affinities, 
thus regulating a single molecular target and increasing the dynamic range of calcium 
sensing (Burgoyne, 2007). In the current work we find that while both hippocalcin and 
neurocalcin-δ slightly increase the apparent calcium sensitivity of IsAHP, within the limits 
of this assay, the calcium sensitivity of these NCS-enhanced IsAHP are indistinguishable. 
As such, these results are inconsistent with the idea that hippocalcin and neurocalcin-δ 
sense different calcium concentrations when regulating IsAHP. Further studies examining 
alternative  hypothesis,  such  differential  cell-type  specific  expression  of  these  NCS 
proteins, are clearly needed to clarify and understand this apparently redundancy.
The results presented in the present work support Tzingounis’ observations (Tzingounis 
et al., 2007) and provide additional information leading to the hypothesis of a broader 
action of NCS proteins on regulation of IsAHP. These results are consistent with the idea 
that  accessory  proteins  from  the  NCS  family,  specifically  the  visinin-like  subgroup, 
regulate the activation of IsAHP in pyramidal neurons of the prefrontal cortex. We also 
show that hippocalcin and neurocalcin-δ not only increased IsAHP amplitude, but also its 
calcium sensitivity, therefore supporting the idea that these NCS proteins sense calcium 
as part of the gating of the IsAHP. Such interpretation is consistent with the results from 
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previous studies showing that IsAHP follows the time course of cytoplasmic calcium (Abel 
et  al.,  2004)  and that  hippocalcin  shuttles  from the  cytoplasm to  the  membrane  in 
response to rises in intracellular calcium, and does so with a time course compatible 
with a role in signaling IsAHP (Markova et al., 2008). However, exactly how these visinin-
like NCS proteins may function in the context of gating IsAHP remains still unclear, and the 
manipulations  used  to  date  leave  open  the  possibility  of  indirect  effects  on  IsAHP 
channels,  for example the facilitation of intermediate steps in the gating process, or 
more broadly, even adaptive changes in excitability.
Having  established  that  visinin-like  members  of  NCS  protein  family  are  important  
molecules for the development of IsAHP,  we then proceeded to investigate the role of 
PtdIns(4,5)P2 in the gating or activation of this current. In the present work we show that 
membrane PtdIns(4,5)P2 plays a key role in the functional expression and gating of IsAHP 
in cortical pyramidal neurons. The first hint that IsAHP could be regulated by PtdIns(4,5)P2 
emerged from the observation that this current runs down upon prolonged whole cell 
recording, a phenomenon that has been seen in other potassium currents, such as Kir 
and  Kv7  potassium  currents,  and  has  been  shown  to  result  from  the  depletion  of 
membrane PtdIns(4,5)P2.  Here we show that IsAHP rundown could be suppressed by 
manipulations  that  facilitate  PtdIns(4,5)P2 biosynthesis,  such  as  increasing  the 
availability of the precursor for PtdIns(4,5)P2 or expressing the synthetic enzyme PIP5K. 
On the other hand, decreasing the levels or availability of membrane PtdIns(4,5)P2 by 
expressing a 5’ phosphatase to reduce its membrane concentration or expression of the 
PH domain of PLCδ1 to sequester it, both resulted in profound suppression of IsAHP.
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One potential confound of the above experiments is that IsAHP is triggered by calcium 
influx,  and  calcium  channel  activity  itself  has  been  shown  to  be  dependent  on 
membrane  PtdIns(4,5)P2.  However  changes  in  IsAHP were  clearly  dissociable  from 
changes in ImAHP, used as a physiological tool to monitor calcium levels, and calcium 
transients imaged at the level of the soma and proximal dendrites. These results make 
unlikely that the observed changes in IsAHP could be explained simply by changes in 
calcium influx;  rather,  they suggest  that  the functional  expression  of  I sAHP is  directly 
dependent on the availability of membrane PtdIns(4,5)P2. These results also suggest 
that, at least under our recording conditions, calcium currents are considerably more 
resistant to reduction in membrane PtdIns(4,5)P2 than IsAHP.
The results obtained from the experiments manipulating the levels of PtdIns(4,5)P2 in 
the membrane, indicate that the functional expression of IsAHP depends on the availability 
of  this phospholipid at  the plasma membrane.  Thus, IsAHP joins a growing list  of  ion 
channels whose activity depends on the presence of membrane PtdIns(4,5)P2 (Suh and 
Hille,  2005).  In  fact,  the  strategies  used  in  the  current  study  to  demonstrate  the 
involvement  of  PtdIns(4,5)P2 were  pioneered  in  a  series  of  now  classic  studies 
addressing the regulation of Kir and Kv7 currents. The main difference is that previous 
studies on isolated cells rely in part on the direct application of PtdIns(4,5)P2 analogs, a 
strategy that is not feasible in brain slices due to limited accessibility to the recorded 
cell. This limitation notwithstanding, the combined results of the present study lead us to 
conclude that IsAHP could be a PtdIns(4,5)P2-sensitive potassium channel.
But how is it that PtdIns(4,5)P2 activates IsAHP? How does it correlate with the calcium-
activated nature of IsAHP? The simplest interpretation would be that IsAHP is carried by a 
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calcium-activated  potassium channel  that  also  requires  PtdIns(4,5)P2 for  its  activity. 
Alternative, it  is also possible that calcium does not directly activate IsAHP but rather 
could  gate  this  current  by  transiently  increasing  the  availability  or  concentration  of 
PtdIns(4,5)P2 in the vicinity of the IsAHP channels. In the present work we tested out these 
possibilities.  In  one  set  of  experiments  we  increased  the  levels  of  membrane 
PtdIns(4,5)P2 through overexpression of PIPK5, the presumed rate limiting enzyme for 
this phospholipids biosynthesis. Remarkably, expression of either of the two isoforms of 
PIP5K failed to increased overall amplitude of IsAHP, which may have been expected if 
PtdIns(4,5)P2 played a permissive role. Equally telling, neither did expression of PIPK5 
occluded IsAHP, which could have been expected if IsAHP was simply gated by an increase 
in  membrane  PtdIns(4,5)P2.  Rather,  increasing  membrane  PtdIns(4,5)P2 robustly 
facilitated  the  ability  of  calcium  influx  to  elicit  IsAHP.  These  results  indicate  that 
PtdIns(4,5)P2 regulates IsAHP downstream from the rise in intracellular calcium. However, 
because the maximum amplitude of IsAHP was not changed, this facilitation is unlikely to 
take place at the level of the channel itself (i.e. the effect is not merely permissive) but  
rather on the ability of calcium to gate IsAHP. Although the exact mechanism underlying 
this phenomenon is not revealed by the current experiments; it is possible to imagine 
several possibilities. For example, calcium could gate IsAHP by transiently increasing the 
local availability of PtdIns(4,5)P2 to the sAHP channels by eliciting the translocation of 
key  PtdIns(4,5)P2 synthesizing  enzymes  to  the  membrane,  or  by  locally  increasing 
PtdIns(4,5)P2 levels by forcing the dissociation of PIP modulins. Alternatively, increases 
in PtdIns(4,5)P2 could facilitate the calcium gating of IsAHP by facilitating the docking of 
NCS proteins at the membrane which in turn will activate sAHP channels. Support for  
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this idea comes from the observations made by O’Callaghan (O'Callaghan et al., 2005).  
In this work, the authors demonstrate a high affinity interaction of the myristoylation 
motif of hippocalcin with PtdIns(4,5)P2, supporting the idea that this phospholipids may 
serve as recruiting spot for NCS proteins after calcium influx.
The results outlined above, while addressing the role of PtdIns(4,5)P2 in the regulation 
of IsAHP, also suggest a possible reinterpretation of the nature of IsAHP. A corollary from 
these findings is that IsAHP may not be an unitary ionic current as usually understood but 
rather may represent the macroscopic manifestation of a calcium-induced increase in 
local PtdIns(4,5)P2 concentration that activates a varying and heterogeneous population 
of PtdIns(4,5)P2 sensitive potassium channels, whose exact composition may depend 
on the cellular context.  In other words, IsAHP may not be so much a current, but the 
embodiment of a biochemical gating mode. If this conjecture is correct, it would explain  
many of  the puzzling properties of  this  current  including  its  extraordinary slow time 
course, its anomalous dependence on intracellular calcium, and why its single channel 
properties and molecular composition appear to be cell dependent.
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One of the most characteristic features of pyramidal cells in the prefrontal cortex 
(PFC) is that they present a slow afterhyperpolarizing current (IsAHP) that plays a critical 
role in the regulation of neuronal excitability.  This current is modulated by receptors 
acting via Gαq/11 G proteins, thus it is thought that neurotransmitters regulate neuronal 
excitability  through  the  inhibition  of  this  current.  IsAHP is  known  to  be  mediated  by 
calcium-activated  potassium  channels,  however,  neither  the  identity  of  the  channel 
underlying this current nor its mechanism of activation are yet well understood. Recent 
reports  have  questioned  a  direct  role  of  calcium  in  the  activation  of  the  channels 
underlying  the IsAHP in  hippocampus,  suggesting the neuronal  calcium sensor  (NCS) 
protein hippocalcin as one of the plausible proteins involved in the triggering of I sAHP; 
therefore, one of the aims of this work will be to examine the role of hippocalcin and 
other NCS proteins in the development of IsAHP in pyramidal neurons of the PFC. 
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In  the  present  study  we  used  loss  of  function  and  overexpression  techniques  to 
demonstrate that hippocalcin is an important component in the development of the I sAHP 
in  pyramidal neurons of the prefrontal  cortex. Furthermore, we also established that 
neurocalcin-δ,  a  close  related  member  of  the  visinin-like  protein  subfamily,  but  not 
VILIP-2  produced  similar  effects  on  IsAHP.  Transfection  with  either  hippocalcin  or 
neurocalcin-δ also altered the kinetic of IsAHP reducing its rate of decay.
Another characteristic feature of IsAHP is that it runs down upon prolonged whole-
cell  recordings.  This  rundown was  reduced when  a  precursor  of  PtdIns(4,5)P2 was 
added to the recording pipette. Furthermore, blocking the resynthesis of PtdIns(4,5)P2, 
greatly  increased  the  rate  of  IsAHP rundown.  Reducing  PtdIns(4,5)P2 levels  or  its 
availability  at  the  plasma  membrane  also  significantly  reduced  IsAHP amplitude, 
highlighting the relevance of this phospholipids in the developing of I sAHP. On the other 
hand,  increasing  PtdIns(4,5)P2 levels  at  the  plasma  membrane,  by  expressing  its 
synthetic enzyme (PIPK5), did not significantly increased IsAHP amplitude but strongly 
increased  its  sensibility  to  activation  by  calcium,  thus  ruling  out  a  direct  role  of  
PtdIns(4,5)P2 on  activation  of  IsAHP in  pyramidal  neurons of  the  PFC.  These results 
propose the idea of an concerted mechanism of IsAHP activation between calcium influx 
and PtdIns(4,5)P2 availability at the plasma membrane and present IsAHP not as a single 
unitary current, but rather as the embodiment of a biochemical gating mode.
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